Biopharma, doctors sue Trump administration over marijuana rescheduling
Source: SeekingAlpha
2026-06-02 10:38:03 ET
More on multi-state operators
- Curaleaf Benefits From Cannabis Rescheduling And International Growth
- Green Thumb Industries Will Benefit From Medical Cannabis Rescheduling
- Cresco Labs Inc. (CRLBF) Q1 2026 Earnings Call Transcript
- State AGs challenge Trump admin medical marijuana shift
- Curaleaf approves 1-for-3 reverse stock split for potential U.S. exchange uplisting
Read the full article on Seeking Alpha
For further details see:
Biopharma, doctors sue Trump administration over marijuana rescheduling
Green Thumb Industries Inc (Sub Voting)
NASDAQ: GTBIF
GTBIF Trading
5.18% G/L:
$8.33 Last:
820,708 Volume:
$8.25 Open:
GTBIF Latest News
June 01, 2026 04:25:00 pm
420 with CNW - DEA Prepares for Hearings on Federal Marijuana Rescheduling
GTBIF Stock Data
$1,446,725,301
201,185,487
1.15%
9
N/A
Pharmaceuticals
Healthcare
US
Chicago
